Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The present study was conducted to find out whether the bioavailability of 150 mg pregabalin
capsules produced by Dexa Medica was equivalent to the reference products (Lyrica® capsule
150 mg, Pfizer Manufacturing Deutschland GmbH, Germany).